EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

HORIBA, Ltd (01H) fair value: what the stock is really worth

As of Oct 1, 2026: fair value of HORIBA, Ltd €115, price €138, upside -16.4%, quality 65 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Technology · DE · Home Japan · ISIN JP3853000002

In Frankfurt, only 4 of the last 21 trading days (30 days) had any turnover. On the other days the price is an indicative quote without trading, so we do not list this stock in the radar. It stays reachable through search.

HL Broad data Sep 30, 2026

HORIBA, Ltd

01H · F

Overvalued / MonitorQuality is not strong enough to offset the price risk.

!Fair value €115.42 · Overvalued (−16.4%)
✓Quality 65/100
✓Healthy Growth (revenue 5y +12.2 %/yr)
✓Solidly profitable · 11.8% net margin (TTM)
✓Low debt · generates free cash flow
✓1.5% dividend yield · Well covered
✓Ranks above peers (11/14)
!Moderate moat 59/100
!Weak on valuation: 15 out of 100
Watch HORIBA, Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€157.13 €34.55 Fair Value €115.42 Jul 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 30, 2026.

How to read this chart

60‑month range €34.55 – €157.13 · fair‑value band €74.10 – €160.82 · the €138.00 price screens above the €115.42 fair value. Dashed = 300-day average. As of Sep 30, 2026.

Follow HORIBA in your weekly email

Every Wednesday you see whether HORIBA is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

HORIBA, Ltd., together with its subsidiaries, provides analytical and measurement solutions in Japan, Asia, the United States, and Europe. It operates in three segments: Energy and Environment; Bio and Healthcare; and Advanced Materials and Semiconductor.

Show more

HORIBA, Ltd., together with its subsidiaries, provides analytical and measurement solutions in Japan, Asia, the United States, and Europe. It operates in three segments: Energy and Environment; Bio and Healthcare; and Advanced Materials and Semiconductor. The company offers mobility products, including systems for emissions measurement, internal combustion engine testing, driveline and powertrain evaluation, brake testing, and wind tunnels; and energy and environment solutions for water and liquid, industrial process, and energy. It also provides life science products comprising fluorescence spectroscopy, raman imaging and spectrometers, and particle characterization; healthcare solutions, which include vitro diagnostic systems for biological analysis, clinical chemistry, veterinary, hematology, and hemostasis; material analysis, such as elemental analysis, molecular and structural analysis, and surface analysis and thin film characterization; and semiconductor products. In addition, the company offers technology solutions comprising health care, fluid control, mass spectrometry, spectroscopy, microscopy and imaging, electrochemistry, physisorption, particle and element analysis, and surface plasmon resonance; and services, including analysis centers, calibration and certification, customer support, spare parts and consumables, testing and consulting, and product and technology training. Its products are used in arts, entertainment, and recreation; biopharma and pharma, biotechnology and biomedical; cosmetics; education, research and development, and government institution; energy solutions; food and beverage; healthcare; industrials; information technology; materials; mobility and transportation; waste management; and water applications. HORIBA, Ltd. was founded in 1945 and is headquartered in Kyoto, Japan.

Stock analysis

HORIBA, Ltd (01H) currently trades at €138.00, while our model-based Fair Value estimate is €115.42, 16.4% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of €124.81 per share, and 6 of the 26 models we run sit above the €138.00 price.

Bear case: the Dividend Discount group reads lowest at €22.90, and 20 of the 26 models stay below the price. Evidence for this calculation is high.

Scenario range: €74.10 (bear) to €160.82 (bull), the price of €138.00 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 65/100 (solid quality), in the Technology sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

HORIBA, Ltd reported revenue of ¥333B in FY2025 versus ¥224B in FY2021, a compound +10.4%/yr. Reported net income was ¥37.1B in FY2025, compounding +14.9%/yr from FY2021.

Key figures

Market cap €5.8B · P/E ratio 24.4 · P/S ratio 2.72 · EPS (TTM) €5.65 · Dividend yield 1.5% · Net margin 11.1% · Return on equity 12.7% · Return on assets (EBIT) 10.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 12% below its 52-week high and 104% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Technology peers we cover trades at −37% fair-value upside, at −16%, 01H screens cheaper than that median.

Fair Value models

Bear €74.10 Fair Value €115.42 Bull €160.82
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF €59.68 €84.80 €122.86 80
Growth DCF €60.02 €81.63 €112.08 79
Owner Earnings €54.46 €76.55 €110.02 77
All 26 models by family
DCF Models
FCF DCF €59.68 €84.80 €122.86 80
Owner Earnings €54.46 €76.55 €110.02 77
5Y Revenue Exit €71.95 €110.85 €161.65 72
5Y EBITDA Exit €101.85 €168.18 €247.71 74
5Y P/E Exit €92.27 €149.80 €211.89 70
10Y Revenue Exit €65.02 €99.19 €147.26 66
10Y EBITDA Exit €85.79 €138.63 €212.97 67
10Y P/E Exit €79.75 €125.99 €185.62 63
Earnings-Based
Graham-Dodd €33.85 €118.36 €159.15 64
Lynch FV €27.56 €39.37 €51.18 61
PEG = 1.0 €27.56 €39.37 €51.18 57
EPV €65.12 €72.80 €79.42 74
Dividend Discount
Gordon GGM €13.35 €26.59 €40.27 67
DDM Multi-Stage €13.35 €22.90 €28.07 67
Multiples
P/E Multiple €104.53 €139.37 €174.22 63
P/S Multiple €63.46 €84.62 €105.77 58
P/B Multiple €63.46 €84.62 €105.77 55
EV/EBIT €144.64 €187.35 €230.06 66
EV/EBITDA €137.62 €177.99 €218.36 67
EV/Revenue €81.29 €109.05 €136.81 54
Asset-Based
NCAV (Graham) €23.39 €31.34 €46.78 54
Growth DCF
Growth DCF €60.02 €81.63 €112.08 79
Rev-Margin DCF €71.95 €110.23 €155.49 72
Economic Profit
Residual Income €41.36 €46.05 €59.18 76
ROIC Compounder €68.84 €83.07 €100.12 72
Growth Earnings
Growth-Adj P/E €87.36 €124.81 €162.25 67

Open the full fair value analysis →

Notify me when 01H reaches fair value

Put 01H on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 65/100

Of which business quality 64 · Market factors (momentum, volatility) 69

Profitability 48
Margins and returns on capital today
Quality Growth 57
Are margins and returns improving?
Cashflow 50
Earnings quality: real cash, not paper profit
Fin. Strength 90
Balance sheet, leverage, solvency risk
Investment 55
Disciplined investing over empire-building
Low Volatility 40
Calm price path (market factor)
Momentum 78
Price trend over the last 3–12 months (market factor)
52W Momentum 89
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 96/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+5.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.2%
Start year 2020 (pandemic). Over 10 years: +6.9% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.6%
What shareholders gained per year (last 5 years), in JPY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in JPY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+20.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+19.2%
Dividend (yield on the price)1.5%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.11% → 16%

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+19.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+11.3%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in JPY, Japan: IMF forecast 2.1% a year to 2030, 1.3% from 2016 to 2025) that is about +16.5% a year for the price and +9.0% for the forecasts.
Forecast 2026 (sales)+16.9%
Forecast 2027 (sales)+11.7%
Projected 2028 (sales)+10.5%
Projected 2029 (sales)+9.3%
Projected 2030 (sales)+8.1%

01H screens overvalued: fair value 16% below the price. Compare with Keysight Technologies, Inc →

Compare HORIBA, Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Scientific & Technical Instruments · 145 stocks

Beats the industry median on 11/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 65 · Above median
Fair Value upside −13.9% · Above median
Profitability
Return on equity (TTM) 12.7% · Top 25%
Return on assets 7.5% · Top 25%
Net margin (TTM) 11.8% · Above median
Operating margin (TTM) 18.9% · Top 25%
Growth and dividend
Revenue growth 23.7% · Top 25%
Dividend yield (TTM) 1.5% · Above median
Balance sheet
Debt / equity 0.11× · Above median

Valuation Multiplesvs Scientific & Technical Instruments median · lower = cheaper

P/E (TTM) 24.4× · Cheaper than median
P/B 2.87× · Pricier than median
P/S (TTM) 2.75× · Cheaper than median
P/FCF 35.4× · Pricier than median
EV/EBITDA 11.5× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)15 · sector 0
FUTURE (revenue growth)100 · sector 29
PAST (return on equity)51 · sector 24
HEALTH (low debt)94 · sector 98
DIVIDEND (yield)30 · sector 18

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Keysight Technologies, Inc KEYS $362.15 $116.07 −68%
Coherent Corp COHR $292.21 $98.35 −66%
Garmin Ltd GRMN $294.14 $304.44 +4%
Chroma ATE Inc 2360 2,295 TWD 614.66 TWD −73%
Teledyne Technologies Incorporated TDY $605.59 $666.15 +10%
AVIC Chengdu Aircraft Company 302132 ¥72.18 ¥19.61 −73%
MKS Inc MKSI $260.82 $199.90 −23%
Fortive Corporation FTV $56.09 $35.20 −37%
Trimble Inc TRMB $57.85 $29.24 −49%
Cognex Corporation CGNX $58.75 $38.10 −35%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

HORIBA, Ltd · Fair Value
€115.42 −16%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "HORIBA, Ltd Fair Value". https://www.fairvalue-calculator.com/stock/01H

Frequently asked questions

Is HORIBA, Ltd (01H) overvalued or undervalued?
As of Sep 30, 2026, our model estimates a fair value of €115.42 versus a price of €138.00, about −16% upside (overvalued).
What is the fair value of 01H?
Our model-based fair value for HORIBA, Ltd is €115.42 (as of Sep 30, 2026), built from audited fundamentals. The current price: €138.00.
What is the quality score of 01H?
HORIBA, Ltd has a Quality Score of 65/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for HORIBA, Ltd (01H)?
Our model-based price target is the fair value of €115.42 (as of Sep 30, 2026) from 26 valuation models. Cautious scenario €74.10, optimistic scenario €160.82. It is a calculation from audited fundamentals, not an analyst target.
What is the HORIBA, Ltd stock forecast for 2026?
Our models put fair value at €115.42, about −16% upside versus a price of €138.00 (overvalued). Cautious scenario €74.10, optimistic scenario €160.82. The calculation is refreshed regularly with new filings.
What is the revenue of HORIBA, Ltd (01H)?
HORIBA, Ltd reported trailing-twelve-month revenue of about ¥364B (latest available figure, as of Sep 30, 2026).
Does HORIBA, Ltd pay a dividend?
HORIBA, Ltd currently shows a dividend yield of about 1.52% relative to its recent price (as of Sep 30, 2026).
What growth is priced into HORIBA, Ltd (01H)?
For today's price to be fair in a discounted-cash-flow model, HORIBA, Ltd would have to grow free cash flow by +19.0 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +12.2 % per year. As of Sep 30, 2026.
What discount rate (WACC) does the fair value of 01H use?
Our models discount HORIBA, Ltd at 9.7 %: a base by market capitalisation (mid), damped by beta 1.10, country premium for Germany. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For HORIBA, Ltd that is +19.0 % per year a year over ten years, using the same discount rate (9.7 %) and the same formula as our fair value.
How much growth has HORIBA, Ltd (01H) delivered so far?
Over the past 5 years revenue at HORIBA, Ltd grew +12.2 % a year. The price currently implies +19.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of HORIBA, Ltd (01H) growing?
The median revenue growth in the sector is +10.0 % a year. That is the yardstick for the growth priced into HORIBA, Ltd (+19.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of HORIBA, Ltd (01H)?
The free-cash-flow yield on the price is 2.75 %: that much free cash flow HORIBA, Ltd produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of HORIBA, Ltd (01H)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For HORIBA, Ltd it is €115.42 per share (as of Sep 30, 2026), against a price of €138.00. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is HORIBA, Ltd stock overvalued or undervalued in 2026?
As of Sep 30, 2026, 01H trades above its calculated fair value: price €138.00, fair value €115.42, a gap of about −16% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 01H?
No. The price is what the market pays today (€138.00); the fair value is what the company's own numbers justify (€115.42). For HORIBA, Ltd the two are €22.58 per share apart. That gap is exactly why we show both numbers side by side.
How much is HORIBA, Ltd worth?
The market values HORIBA, Ltd at about €5.8B (market capitalisation, as of Sep 30, 2026). Per share that is €138.00; our models calculate a fair value of €115.42 per share.
What do the bullish and bearish scenarios say about 01H?
Our models span a range for HORIBA, Ltd: cautious scenario €74.10, base €115.42, optimistic €160.82 per share (as of Sep 30, 2026, price €138.00). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 01H?
HORIBA, Ltd trades at a price-to-earnings ratio of 24.4 (as of Sep 30, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €115.42 is built from several models across several years. Other multiples: P/B 2.9, P/S 2.7, EV/EBITDA 11.5.
How solid is the balance sheet of HORIBA, Ltd (01H)?
Balance-sheet figures for HORIBA, Ltd (as of Sep 30, 2026): return on equity 12.7%, debt of 0.11 per unit of equity. They feed the Quality Score of 65/100, which measures business quality independently of the share price.
How far is 01H from its 52-week high?
HORIBA, Ltd trades at €138.00, about 12% below its 52-week high of €157.13 and 104% above the low of €67.50 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of €115.42 is for.
Which stocks are comparable to HORIBA, Ltd?
From the same area (Technology) we also value Keysight Technologies, Inc, Coherent Corp, Garmin Ltd, Chroma ATE Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is HORIBA, Ltd stock attractive at the current price?
The data as of Sep 30, 2026: price €138.00, calculated fair value €115.42 (−16%), Quality Score 65/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 01H calculated?
We run HORIBA, Ltd through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €115.42, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. HORIBA, Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of HORIBA, Ltd (01H)?
The closing price on Oct 1, 2026 was €138.00. Our model-based fair value is €115.42, about −16% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with HORIBA, Ltd right now?
Solid but not exceptional quality (65/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (€74.10 to €160.82) leaves room in how you read the outcome.

Key figures of HORIBA, Ltd

How large is the market capitalisation of HORIBA, Ltd (01H)?
The market capitalisation of HORIBA, Ltd is €5.8B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of HORIBA, Ltd (01H)?
The price-to-sales ratio of HORIBA, Ltd is 2.72 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of HORIBA, Ltd (01H)?
Earnings per share at HORIBA, Ltd are €5.65 (price ÷ EPS = P/E 24.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of HORIBA, Ltd (01H)?
The dividend yield of HORIBA, Ltd is 1.5% (payout 37.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of HORIBA, Ltd (01H)?
The net margin of HORIBA, Ltd is 11.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of HORIBA, Ltd (01H)?
The return on equity (ROE) of HORIBA, Ltd is 12.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of HORIBA, Ltd (01H)?
On an EBIT basis the return on assets of HORIBA, Ltd is 10.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of HORIBA, Ltd (01H)?
The operating margin of HORIBA, Ltd is 18.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at HORIBA, Ltd (01H)?
Revenue at HORIBA, Ltd is growing +23.7% versus a year earlier (3y avg +7.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at HORIBA, Ltd (01H)?
Earnings per share at HORIBA, Ltd are growing +69.6% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch HORIBA, Ltd in the live analysis

One click puts HORIBA, Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.